[go: up one dir, main page]

DK1214058T3 - Fremgangsmåde til opnåelse af mikorpartikler - Google Patents

Fremgangsmåde til opnåelse af mikorpartikler

Info

Publication number
DK1214058T3
DK1214058T3 DK00963188T DK00963188T DK1214058T3 DK 1214058 T3 DK1214058 T3 DK 1214058T3 DK 00963188 T DK00963188 T DK 00963188T DK 00963188 T DK00963188 T DK 00963188T DK 1214058 T3 DK1214058 T3 DK 1214058T3
Authority
DK
Denmark
Prior art keywords
micor
particles
obtaining
polymer
active substance
Prior art date
Application number
DK00963188T
Other languages
English (en)
Inventor
Brita Sjoeblom
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1214058T3 publication Critical patent/DK1214058T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Drying Of Solid Materials (AREA)
DK00963188T 1999-09-10 2000-09-01 Fremgangsmåde til opnåelse af mikorpartikler DK1214058T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903236A SE9903236D0 (sv) 1999-09-10 1999-09-10 Method to obtain microparticles
PCT/SE2000/001682 WO2001019345A1 (en) 1999-09-10 2000-09-01 Method to obtain microparticles

Publications (1)

Publication Number Publication Date
DK1214058T3 true DK1214058T3 (da) 2003-11-03

Family

ID=20416948

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00963188T DK1214058T3 (da) 1999-09-10 2000-09-01 Fremgangsmåde til opnåelse af mikorpartikler

Country Status (12)

Country Link
US (2) US6753014B1 (da)
EP (1) EP1214058B1 (da)
JP (1) JP2003509361A (da)
AT (1) ATE245022T1 (da)
AU (1) AU775458B2 (da)
CA (1) CA2382005A1 (da)
DE (1) DE60003933T2 (da)
DK (1) DK1214058T3 (da)
ES (1) ES2200933T3 (da)
NZ (1) NZ517525A (da)
SE (1) SE9903236D0 (da)
WO (1) WO2001019345A1 (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2236700T3 (es) 1993-11-19 2005-07-16 Janssen Pharmaceutica N.V. 1,2-benzazoles microencapsulados.
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
US6284283B1 (en) * 1999-10-21 2001-09-04 Alkermes Controlled Therapeutics, Inc. Method of producing sub-micron particles of biologically active agents and uses thereof
EP2295043A1 (en) 1999-10-29 2011-03-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
GB0004827D0 (en) * 2000-02-29 2000-04-19 Quadrant Holdings Cambridge Compositions
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US6824822B2 (en) 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
EP2932964A1 (en) 2000-10-30 2015-10-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles
US20050161845A1 (en) * 2001-12-10 2005-07-28 Alfred Haas Production and shaping of shaped bodies by means of low-temperature cooling an drying processes
GB2399084B (en) 2002-07-30 2007-01-31 Univ Liverpool Porous beads and method of production thereof
CN100366249C (zh) * 2002-09-29 2008-02-06 天津帝士力投资控股集团有限公司 一种替莫唑胺控释给药系统
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
AU2004298719B8 (en) * 2003-12-19 2011-04-07 Alk-Abello A/S Cryogranulation and storage method for active pharmaceutical agents
NZ548330A (en) 2004-01-28 2010-03-26 Unilever Plc Porous materials and method of production thereof
GB0401947D0 (en) * 2004-01-28 2004-03-03 Unilever Plc Porous bodies and method of production thereof
GB0401950D0 (en) * 2004-01-28 2004-03-03 Unilever Plc Porous bodies and method of production thereof
CN1968700A (zh) 2004-04-15 2007-05-23 阿尔克姆斯有限公司 聚合物基的持续释放装置
US7456254B2 (en) 2004-04-15 2008-11-25 Alkermes, Inc. Polymer-based sustained release device
ITRM20040539A1 (it) * 2004-11-02 2005-02-02 Mavi Sud S R L Preparati a base di chitina o suoi derivati per uso cosmetico o medico.
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
EP1726299A3 (en) 2005-05-27 2007-04-18 StratoSphere Pharma AB Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
US8017152B2 (en) 2005-05-27 2011-09-13 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
WO2007056205A2 (en) * 2005-11-04 2007-05-18 Eastman Chemical Company Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents
US20080069891A1 (en) * 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US20080075777A1 (en) * 2006-07-31 2008-03-27 Kennedy Michael T Apparatus and methods for preparing solid particles
AU2007284759B2 (en) 2006-08-09 2010-10-28 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
GB0707612D0 (en) * 2007-04-19 2007-05-30 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
RU2440097C2 (ru) 2007-04-23 2012-01-20 Интарсия Терапьютикс, Инк. Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления
US8343140B2 (en) 2008-02-13 2013-01-01 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US9504274B2 (en) 2009-01-27 2016-11-29 Frito-Lay North America, Inc. Methods of flavor encapsulation and matrix-assisted concentration of aqueous foods and products produced therefrom
US20100189845A1 (en) * 2009-01-27 2010-07-29 Frito-Lay North America Inc. Flavor Encapsulation and Method Thereof
WO2011037623A1 (en) 2009-09-28 2011-03-31 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
US8927025B2 (en) 2010-05-11 2015-01-06 Cima Labs Inc. Alcohol-resistant metoprolol-containing extended-release oral dosage forms
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
WO2015065547A1 (en) 2013-10-31 2015-05-07 Cima Labs Inc. Immediate release abuse-deterrent granulated dosage forms
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
CA3024479A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
JP7286542B2 (ja) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法
JP2019131511A (ja) * 2018-01-31 2019-08-08 理研ビタミン株式会社 薬物含有粒子の製造方法
US20220062200A1 (en) 2019-05-07 2022-03-03 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
WO2020225773A1 (en) 2019-05-07 2020-11-12 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4845950A (da) * 1971-10-13 1973-06-30
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
JPS61218516A (ja) * 1985-03-25 1986-09-29 Ichimaru Fuarukosu Kk 徐放性マイクロカプセルの製造法
AU620253B2 (en) 1989-05-01 1992-02-13 Alkermes Controlled Therapeutics, Inc. Process for producing small particles of biologically active molecules
US5017383A (en) * 1989-08-22 1991-05-21 Taisho Pharmaceutical Co., Ltd. Method of producing fine coated pharmaceutical preparation
US5102983A (en) * 1990-04-02 1992-04-07 United States Surgical Corporation Process for preparing foamed, bioabsorbable polymer particles
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
NZ279549A (en) * 1994-02-09 1996-11-26 Kinerton Ltd Obtaining solid material by drying a solution thereof, supercooled spray of solution expanded into vacuum and frozen droplets collected
WO1997007788A2 (en) * 1995-08-31 1997-03-06 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of an agent
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
GB2329124B (en) 1997-09-12 2002-05-08 Hiran Asoka Malinga Ratwatte Method of forming dose units of active agents

Also Published As

Publication number Publication date
CA2382005A1 (en) 2001-03-22
DE60003933T2 (de) 2004-06-03
US6753014B1 (en) 2004-06-22
US20040219222A1 (en) 2004-11-04
EP1214058A1 (en) 2002-06-19
DE60003933D1 (de) 2003-08-21
SE9903236D0 (sv) 1999-09-10
JP2003509361A (ja) 2003-03-11
ES2200933T3 (es) 2004-03-16
AU775458B2 (en) 2004-08-05
ATE245022T1 (de) 2003-08-15
EP1214058B1 (en) 2003-07-16
WO2001019345A1 (en) 2001-03-22
NZ517525A (en) 2003-08-29
AU7463700A (en) 2001-04-17

Similar Documents

Publication Publication Date Title
DK1214058T3 (da) Fremgangsmåde til opnåelse af mikorpartikler
DE60022664D1 (de) Herstellungsverfahren von submikrometerwirkstoffpartikeln
SE0100823D0 (sv) Method I to obtain microparticles
BR0214279A (pt) Composições farmacêuticas em forma particulada
Desai et al. Critical factors affecting cell encapsulation in superporous hydrogels
WO2004058218A3 (en) Prefilming atomizer
DE60034565D1 (de) Verfahren zur herstellung eines umhüllten geschmackmaskierten granulats mit sofortiger wirkstofffreisetzung
NZ335133A (en) Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof for treating cancer
FR2753639B1 (fr) Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
DK0432232T3 (da) Fremgangsmåde til fremstilling af små partikler af biologisk aktive molekyler
DE60027266D1 (de) Vorrichtung zur aufbereitung einer medizinischen flüssigkeit
DE69814885D1 (de) Verfahren zur herstellung von arzneiformen mit kontrollierter wirkstoffabgabe auf polymerbasis
DK1689425T3 (da) Farmaceutiske formuleringer til frisætning i længere tid af et eller flere aktive stoffer samt deres terapeutiske anvendelser
AR017752A1 (es) Composicion de matriz solida y porosa, metodo para su preparacion y metodo para la liberacion controlada de un agente terapeutico utilizando dichamatriz
NO20074092L (no) Tabletter for forbedret legemiddel dispersibilitet
IL153046A (en) Prolonged release microspheres for injection delivery and preparation method
WO2001015734A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
ATE556788T1 (de) Herstellung pharmazeutischer wirkstoffpartikel unter verwendung fokussierter akustischer energie
DE60030999D1 (de) Verfahren zur herstellung von teilchen
BR0213220A (pt) Processo de preparação de compostos de interação de uma substância ativa pouco solúvel em um meio aquoso com um suporte poroso, e, composto de interação de interação de uma substância ativa pouco solúvel em um meio aquoso em um suporte aquoso
CN106236605A (zh) 多孔微球及其制备方法、应用
CN102697738A (zh) 二氧化碳流体抗溶剂法制备多孔微球的方法
MY142014A (en) A lipase powder, methods for producing the same and use thereof
BR0115572A (pt) Processos e aparelho para o resfriamento de filamentos em um processo de formação de filamentos
TW200502039A (en) Process for the preparation of catalyst microspheres